| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6113698 | Critical Reviews in Oncology/Hematology | 2013 | 8 Pages |
Abstract
Although safety concerns do exist, ESA therapy can be considered for use in patients with chemotherapy-induced anemia in accordance with Health Canada labeling.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Janis Bormanis, Ian Quirt, José Chang, C. Tom Kouroukis, David MacDonald, Barb Melosky, Sunil Verma, Felix Couture,